Literature DB >> 26281899

[Measurement of disease severity in dermatology].

S Deckert1, C Apfelbacher2, J Schmitt3,4.   

Abstract

In order to determine the appropriate therapy for dermatological diseases, numerous measurement instruments are available to measure disease severity. Due to the lack of laboratory parameters for some dermatological diseases to objectify the disease severity (e.g., atopic dermatitis, psoriasis), questionnaires are used. Laboratory as well as questionnaire-based measurements should be reliable, valid, and sensitive to change. In addition, measurement instruments should be feasible. Classifications of disease severity which are based on inadequate measurement properties result in incorrect clinical decisions and limit evidence-based healthcare. Therefore, systematically developed and evidence-based recommendations for the use of individual measurement instruments should be taken into consideration.

Entities:  

Keywords:  Measurement instrument; Questionnaires; Reliability; Sensitivity to change; Validity

Mesh:

Year:  2015        PMID: 26281899     DOI: 10.1007/s00105-015-3663-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  20 in total

1.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

Review 2.  Outcome measures of disease severity in atopic eczema.

Authors:  C Charman; H Williams
Journal:  Arch Dermatol       Date:  2000-06

3.  [Health services research the example of atopic dermatitis].

Authors:  J Schmitt
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

4.  Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis.

Authors:  J Berth-Jones
Journal:  Br J Dermatol       Date:  1996-09       Impact factor: 9.302

Review 5.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

Review 6.  What are the best outcome measurements for atopic eczema? A systematic review.

Authors:  Jochen Schmitt; Sinead Langan; Hywel C Williams
Journal:  J Allergy Clin Immunol       Date:  2007-10-01       Impact factor: 10.793

Review 7.  Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.

Authors:  Evelien Roekevisch; Phyllis Ira Spuls; Denise Kuester; Jacqueline Limpens; Jochen Schmitt
Journal:  J Allergy Clin Immunol       Date:  2013-10-24       Impact factor: 10.793

Review 8.  Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

Authors:  Balvinder Rehal; April W Armstrong; April Armstrong
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

9.  Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist.

Authors:  Caroline B Terwee; Lidwine B Mokkink; Dirk L Knol; Raymond W J G Ostelo; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2011-07-06       Impact factor: 4.147

Review 10.  Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.

Authors:  Jochen Schmitt; Sinéad Langan; Stefanie Deckert; Ake Svensson; Laura von Kobyletzki; Kim Thomas; Phyllis Spuls
Journal:  J Allergy Clin Immunol       Date:  2013-09-12       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.